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Background: Commonly used conservative shoulder pain treatments include: advice/analgesia, exercise/manual therapy and,
corticosteroid injection. Moderators, patient/clinical attributes influencing treatment effect, facilitate clinical decision-making by
identifying which patients might respond best to specific treatments. This review summarises results of studies aiming to identi-
fy/test treatment effect moderators.Methods: Randomised controlled trials (RCTs) containing some form of, or suggested moder-
ation/subgroup analysis (sample size >20, and >10 subjects in smallest subgroup), comparing above treatments against physical/
functional/pain outcomes, in adults with shoulder pain were searched for in Medline, Embase, PsychInfo, CINAHL, AMED, Pedro,
Cochrane Database. Cochrane Risk of Bias tool and Pincus criteria for moderation analysis were applied.Results: Six RCTs aiming
to identify/test moderators and 16 suggesting potential moderators were included and data narratively synthesised. One trial
offered confirmatory level moderation (Pincus criteria). Graded exercise had smaller effect in those with painful arc at baseline,
compared against without, although lacked statistical significance (mean difference −14.0 shoulder disability (0–100 scale), 95%
CI’s [−28.1, 0.1], p = 0.05). Twenty other factors with insufficient level moderation evidence were identified.Discussion: Review
highlights lack of high-quality evidence for moderators of treatment effect of shoulder pain treatments. Future research should
address proposed candidate moderators, using robust moderation methodologies to inform clinical decision-making.
Keywords: Shoulder   ; physiotherapy   ; primary care   ; systematic review   ; clinical reasoning   ; evidence based physiotherapy/
medicine; EBM   ; methodology   
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Introduction
Primary care is commonly the first point of access for individuals with shoulder pain. Although half of those with
shoulder pain consult their GP only once [1,2], apart from back and knee pain, primary care consultation rates for
shoulder disorders are disproportionately higher than other MSK conditions [3,4]. Shoulder pain has a poor pattern of
recovery (prognosis); >70% have pain for more than 6 weeks [5] and only 50% of new episodes demonstrate com‐
plete recovery within six months [6–8], rising to only 60% after 12 months [7]. Effective first-line treatment of shoul‐
der pain, therefore, remains a significant clinical challenge.
1
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In spite of numerous randomised controlled trials (RCTs) in shoulder pain that demonstrate short-term intervention
effectiveness, including for exercise and corticosteroid injection [9–14], evidence is lacking for interventions with
long-term effectiveness or that achieve clinically meaningful treatment effects. Variable prognosis of patients with
shoulder pain [6,8,15], coupled with acknowledged diagnostic challenges [16], have prompted the exploration of
prognosis-based first-line treatment strategies.
Recent shoulder studies and reviews have identified predictors of outcome regardless of treatment (prognostic fac‐
tors), or investigated predictors of outcome in a cohort of patients all receiving similar treatments (e.g. physiotherapy-
led intervention) [17–20]. However, predictors of outcome in such clinical cohorts do not aid understanding of how
patient outcomes may vary in response to different treatments, or to treatment versus no treatment. Moderators of
treatment effect are patient/clinical attributes that influence the effect of treatment [21], facilitating clinical decision-
making by identifying the likely responders (and non-responders) to specific treatments [22]. Currently, the key mod‐
erators for commonly used first-line interventions for shoulder pain are unknown.
Aims of the review
We, therefore, undertook a systematic review to inform the first-line treatment decision-making by summarising
the available evidence of potential moderators for three commonly used shoulder pain interventions: advice and anal‐
gesia, exercise and/or manual therapy and corticosteroid joint injection. To achieve this aim, we sought to identify
studies that make a differential treatment recommendation. These studies were divided into two categories: (i) studies
that aimed to identify or test treatment moderators and conducted a form of moderation analysis and (ii) studies that
suggested, without data analysis, a potential moderator.
Methods
A systematic review was undertaken that
1. Searched for randomised controlled trials in shoulder pain that aimed to analyse moderation or
included suggestions of potential moderators for the following commonly used first-line treat‐
ments: (a) education, advice, analgesia; (b) exercise and/or strengthening exercise; and (c) corti‐
costeroid injection
2. Identified and appraised the methods used to identify moderators
3. Identified potential moderators for (a) advice and analgesia, (b) exercise and/or strengthening ex‐
ercise and (c) corticosteroid injections in patients with musculoskeletal shoulder pain, to inform
the first-line treatment decision making.
Types of studies
Included studies were randomised controlled trials (gold standard for revealing moderators of treatment effect;
[23,24]); that aimed to identify or test treatment moderators and/or conducted moderation analyses or any form of
subgroup analysis where patients were grouped on the basis of pre-determined prognostic factors and the treatment
effect was compared across subgroups. Included studies had a minimum number of 10 participants in the smallest
subgroup [25] to have sufficient sample size in which to determine meaningful subgroup effects [26].
Types of participants
Studies included adults (aged 18 years or older) with non-traumatic, unilateral musculoskeletal shoulder pain.
Non-traumatic musculoskeletal shoulder pain was defined as soft tissue strains/sprains, tendonitis, bursitis, capsulitis
within or local to the glenohumeral joint. Studies including patients with traumatic, inflammatory, rheumatological,
degenerative conditions, or osteoarthritis were excluded from this review.
Types of interventions
Included studies involved one or more of the following most commonly used first-line interventions:
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1. Education, advice and/or pain relief delivered by a healthcare practitioner.
2. Mobilising or strengthening exercise or manual therapy treatment to joints and/or soft tissue de‐
livered by a physiotherapist or physical therapist (USA definition).
3. Corticosteroid injection delivered by a primary care doctor (GP), rheumatologist, orthopaedic
surgeon, physiotherapist or physical therapist.
Outcomes of interest
Studies were included if they had at least one functional (including joint assessment, disability, or work) or pain-
related outcome.
Search methods for identifying studies
Database (Medline, Embase, PsycINFO, CINAHL, AMED, Pedro, and Cochrane) searches began at the earliest
offered date. Searches were conducted up to January 2019. Search terms (Table 1) for shoulder conditions and rele‐
vant interventions were identified from Cochrane reviews [27,28] and supplemented with key words from previous
reviews and relevant research studies. A methods filter was used to identify RCTs [29]. Inclusion of additional publi‐
cations was identified through supplemental searching of included article reference lists and liaison with clinical and
academic experts in the field of shoulder pain.
Table 1. Systematic review search terms (Medline).
1 Shoulder Pain/
2 Shoulder Impingement Syndrome/
3 Rotator Cuff/
4 ((shoulder* or rotator cuff) adj5 (bursitis or frozen or impinge* or tendinitis or tendonitis or pain*)).mp. [mp = 
title, abstract, original title, name of substance word, subject heading word, protocol supplementary concept, rare
disease supplementary concept, unique identifier]
5 rotator cuff.mp. [mp = title, abstract, original title, name of substance word, subject heading word, protocol sup‐
plementary concept, rare disease supplementary concept, unique identifier]
6 adhesive capsulitis.mp. [mp = title, abstract, original title, name of substance word, subject heading word, proto‐
col supplementary concept, rare disease supplementary concept, unique identifier]
7 capsular syndrome.mp. [mp = title, abstract, original title, name of substance word, subject heading word, proto‐
col supplementary concept, rare disease supplementary concept, unique identifier]
8 exp Bursitis/
9 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8
10 exp Rehabilitation/
11 exp Physical Therapy Modalities/
12 exp Musculoskeletal Manipulations/
13 exp Exercise Movement Techniques/
14 (rehabilitat* or physiotherap* or physica therap* or manual therap* or exercise* or mobilis*).mp. [mp = title, ab‐
stract, original title, name of substance word, subject heading word, protocol supplementary concept, rare disease
supplementary concept, unique identifier]
15 10 or 11 or 12 or 13 or 14
16 exp Injections/
17 ((steroid* or corticosteroid* or subacromial or sub-acromial) adj5 inject*).mp. [mp = title, abstract, original title,




19 "joint inject*".mp. [mp = title, abstract, original title, name of substance word, subject heading word, protocol
supplementary concept, rare disease supplementary concept, unique identifier]
20 ((corticosteroid or triamcinolone or lederspan or hydrocortisone or methylprednisolone or depo medro* or anti
inflammat*) adj inject*).ab,ti.
21 16 or 17 or 18 or 19 or 20
22 clinical trial.pt.
23 random*.mp. [mp = title, abstract, original title, name of substance word, subject heading word, protocol supple‐
mentary concept, rare disease supplementary concept, unique identifier]
24 ((single or double) adj (blind* or mask*)).mp. [mp = title, abstract, original title, name of substance word, subject
heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier]
25 placebo*.mp. [mp = title, abstract, original title, name of substance word, subject heading word, protocol supple‐
mentary concept, rare disease supplementary concept, unique identifier]
26 22 or 23 or 24 or 25
27 9 and 15 and 21 and 26
Study selection
Studies were selected based on the criteria in Table 2. One reviewer applied the selection criteria to retrieve publi‐
cation titles. Two reviewers independently screened each abstract and 10 abstracts were triple screened for eligibility.
Full texts were subjected to data extraction, risk of bias assessment and methodological appraisal by two reviewers.
Reviewers did not assess studies where they declared conflict of interest by authorship/collaboration.
Table 2. Selection criteria for studies to be included in the review.
Inclusion criteria Exclusion criteria
RCT design Non-RCT design
Adult human participants Non-human or child participants
Musculoskeletal shoulder pains: Dysfunction, pain or symp‐
toms in the glenohumeral region ± surrounding soft tissue in‐
cluding but not limited to: soft tissue strains/sprains, tendoni‐
tis, bursitis, capsulitis
Traumatic shoulder pains e.g. fracture or dislocation
Comparison of one or more of the below against each other
or any other intervention:(i) Advice, education and pain re‐
lief (delivered by a primary care health professional(ii) Man‐
ual therapy and/or strengthening and/or mobilising exercises
delivered by a Physiotherapist or Physical Therapist(iii) Cor‐
ticosteroid injection (± analgesia)
Comparison of any of the below exclusively against a
control: (i) Advice, education and pain relief (deliv‐
ered by a primary care health professional(ii) Manual
and/or strengthening and/or mobilising exercises deliv‐
ered by a Physiotherapist or Physical Therapist (iii)
Corticosteroid injectionNon-steroid and/or analgesic
injections e.g. hyaluronic acid
Any attempt at subgroup analysis Failure to conduct any form of subgroup analysis
Outcome measured using multiple measures: physical, func‐
tional or pain
Solely occupational/work function or absenteeism/
presenteeism outcome measures
More than 20 participants in trial (minimum 10 per arm) Less than 20 participants in trial (under 10 per arm)
Data extraction
Data extraction and appraisal forms were piloted using a published secondary data analysis of a large RCT in back




The Cochrane Risk of Bias (ROB) tool [29] was applied in each included study to estimate likelihood that the
reported intervention effect is true, i.e. the extent to which results of a study are valid.
Assessment of methodological quality of moderation analysis
The quality of moderation analyses in included studies was assessed using criteria defined by [24]: a priori and
evidence-based hypotheses, measurement of moderators prior to randomisation, reliability and valid outcome and
process factors and an explicit test of interaction between outcome and moderator. Formal and valid moderation anal‐
ysis in a randomised controlled trial consists of stratified or subgroup analysis (of both intervention and comparator
group), defined a priori in the trial protocol, powered to detect significant differences, with presentation of treatment
effects for categories of the potential moderator [31,32]. Subgroup significance testing is generally conducted in re‐
gression analysis by adding a ‘moderator * treatment’ interaction term to the model, which also includes treatment
and predictor variables [32]. Each study was classified according to these criteria as having confirmation, exploratory
or insufficient levels of evidence of moderation.
Evidence synthesis
A meta-analysis or meta-regression was not possible because of the heterogeneity in patient population, settings,
interventions, and outcomes used. Studies included in this review were divided into (i) studies aiming to identify or
test treatment moderation and/or some form of moderation or subgroup analysis, and (ii) studies that suggested poten‐
tial moderators of treatment effect without formal analyses.
Assessment of risk of bias and quality appraisal was only conducted on studies with moderation analysis (group i
above). A narrative synthesis describing identified subgroup analyses, taking account of risk of bias and listing candi‐
date moderators in trials without formal moderation analysis was conducted.
Results
A PRISMA flow diagram [33] is presented in Figure 1. Electronic database searches identified 1869 citations. Af‐
ter removing duplicates, titles of 1275 citations were screened and 890 studies were removed. With consensus from
two reviewers, a further 293 studies were removed. Ninety-two full texts were read, and 21 articles were deemed
relevant. Reference list screening identified seven further articles, one of which was included in the review. In total,
22 studies were included in this review, six of which attempted moderation analysis or included a formal moderation
analysis (Table 3). Data on inclusion and exclusion criteria, primary outcome, follow-up, interventions studies and
treatment duration are presented. Table 4 details the moderation analysis design of each study listed in Table 3.
Figure 1. PRISMA systematic review flow chart.
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Table 3. Description of Studies attempting moderation analysis.
Reference, set‐
ting, country
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4/52, 8/52 Control and criteria-control groups:
passive mobilisation & stretching
techniques, electrotherapy modali‐
ties, and active exercises, twice
weekly, 3/12. End-range mobilisa‐
tion/scapular mobilisation treatment
approach (EMSMTA): control treat‐
ment PLUS mobilisation and scapu‐
lar mobilisation, twice weekly,
3/12.
×/52 denotes × weeks. ×/12 denotes × months.
PGAS: Patient Global Assessment of Satisfaction; PGIC: Patient Global Impression of Change; SDQ: Shoulder Disa‐
bility Questionnaire; FLEX-SF: Flexi-Level Scale of Shoulder Function; Mg/mL: milligrams per millilitre.
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Hot pain quality: Greater improve‐
ment with injection compared to
heated lidocaine/tetracaine patch in
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score) interaction is statistically sig‐
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moderators. The final mod‐
el includes: treatment vari‐
able (graded exercise or
not), change in pain inten‐
sity (prognostic factor),
painful arc (potential mod‐
erator, and treatment × 
painful arc interaction
Painful arc: Less improvement in the
shoulder disability questionnaire
scores with graded exercise therapy
compared to usual care in patients
with a painful arc at baseline versus
those without painful arc. Interaction
term between graded exercise thera‐
py and painful arc is reported as sig‐
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The relationship of pre-ran‐
domisation treatment pref‐
erence (candidate predic‐
tor) and functional outcome
was examined within three
groups: those with no treat‐
ment preference, those who
did receive their preferred
treatment, and those who
did not receive their prefer‐
red treatment
Treatment preference: treatment ef‐
fect was not moderated by having
preference or whether preference
was met. Similar difference in out‐
come were reported regardless of
treatment preference (good outcome
in those receiving preferred treat‐
ment = 55% injection versus 58%
physiotherapy; not receiving prefer‐
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rates across treatment pref‐
erence subgroups (potential
moderator): those without a
preference; those allocated
to preferred intervention;
those not allocated to pre‐
ferred intervention
Treatment preference: Allocation of
preferred treatment appears to have a
positive, potentially moderating
treatment effect for injections com‐
pared with physiotherapy. Complete
recovery or considerable improve‐
ment was 85% for patients who pre‐
ferred and received injection versus
43% for those who preferred and re‐
ceived physiotherapy (difference
42%); and 64% (injection) versus
50% (physiotherapy) in those not al‐



























Patients were first classi‐
fied into persistent-recur‐
rent and recovery groups
using principal components
analysis (PCA) and cluster
analysis. Next, regression
models were used to ex‐
plore baseline characteris‐
tics associated with shoul‐
der pain recovery profiles,
including age, sex, pain du‐
ration, previous trauma,
previous shoulder pain epi‐
sodes, and overuse as pos‐
sible cause of shoulder
pain. Treatment was added
to the model as a covariate
Age, gender: In the injection group
(mostly younger than 60 years old
and male), pain severity reduced
faster than in those treated with
physiotherapy. The authors conclude
that: “patients who were treated with
corticosteroid injections would get
faster recovery from shoulder pain
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mixed models were used to
estimate the effect of treat‐
ment on all outcomes.
Baseline level of the out‐
come variable was included
as a covariate, and treat‐
ment and time were inclu‐
ded as factors in the model
Patients who met kinematic criteria
(having 8°scapular posterior tipping,
97° humeral elevation, and 39° hum‐
eral external rotation during arm ele‐
vation) had better outcomes from
physiotherapy plus mobilisations
(EMSMTA). Subjects in the EMSM‐
TA group experienced greater im‐
provement in outcomes compared
with the criteria-control group at 4
weeks (21% of hand behind back,
95% CI [0.04, 0.37], p = 0.005).) and
at 8 weeks, the humeral external ro‐
tation and the hand-behind-back
reach improved in the manual thera‐
py group as compared with the crite‐
ria-control group (23.4 degrees, 95%
CI [8.2, 37.3] and 33%, 95% CI
[0.17, 0.44], p = 0.002 and p < 
0.0005. At 8 weeks, the Flexi-Level
Scale of Shoulder Function (FLEX-
SF) disability score improved in the
manual therapy as compared with the
criteria-control group (7.4 scores,






















Characteristics of studies formally evaluating moderation
Of the 22 included studies, six studies formally evaluated moderation (Table 1). Study setting varied between pri‐
mary care and secondary care, as well as country (Netherlands, UK, USA, and Taiwan). Diagnoses of participants
varied between chronic shoulder pain, unilateral shoulder pain, shoulder pain, and painful, stiff shoulder. Five studies
examined a form of physiotherapy or exercises (mobilising, stretching or strengthening exercises, joint mobilisations
or soft tissue massage), four studies trialled corticosteroid injection and one study examined electrotherapy (pulsed
ultrasound, short wave diathermy, laser and radial extracorporeal shockwave treatment). All six studies used out‐
comes for either function, disability, and/or work whilst three used visual analogue scales (VAS) for pain.
Risk of bias
Risk of bias was assessed for the six moderation studies (Figure 2). Two trials had minimum risk of bias [35,39],
and four demonstrated some potential for bias. Van der Windt et al. (1998) and Zheng et al. [38] (separate analysis of
the same trial) demonstrated potential for selection bias and attrition bias as attrition rate and sequence generation
methods were not reported. Only one subgroup analysis was reported and long-term data was not presented by van
der Windt et al. [37] or Zheng et al. [38], raising potential for reporting bias. Gammaitoni et al. [34] demonstrated
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high risk of detection bias due to open label trial design, whilst insufficient information was presented to judge risks
of selection, performance or attrition biases.
Figure 2. Risk of bias item for studies containing attempted moderation analysis.
Quality appraisal of statistical methods for moderation
Conventionally, treatment moderators are identified through testing the interaction between a prognostic factor and
a treatment variable [40,41], and/or through a priori defined subgroup analyses. Table 4 outlines the approaches taken
to identify potential moderators of treatment effect in studies included in this review. Table 5 shows how each of the
studies performed against the Pincus criteria [24] for the identification of moderators. Only one study [35] provided a
methodologically valid analysis of moderator of treatment effect: presence of painful arc led to a smaller effect on
shoulder disability (0–100) of graded exercise therapy compared with usual care only (adjusted mean difference −0.2
for those with painful arc, and 7.3 for those without painful arc at baseline). The interaction test was not statistically
significant (regression coefficient −14.0, 95% confidence interval: 028.1–0.1, p = 0.05). Seven other potential moder‐
ators of outcome were identified that were supported by exploratory level evidence: hot pain quality [34]; treatment
preference [36,37]; age [38]; gender [38]; and three specific degrees of scapular and humeral joint positions [39].
Only studies by Geraets et al. [35] and Gammaitoni et al. [34] explicitly tested the interaction between each candidate
moderator and specific treatments. Although most studies had evidence-based hypotheses for moderation studies,
Gammaitoni et al. [34] and van der Windt et al. [37] did not. It should also be noted that subgroup sizes for all analy‐
ses were small and, therefore, offered insufficient statistical power to test moderation.



















































Geraets et al. [35] Yes Yes Yes Yes Yes 5 Confirmatory
Thomas et al. [36] Yes Yes Yes Yes No 4 Insufficient
van der Windt et al.
[37]
No No Yes Yes No 2 Insufficient
XZheng (2005)
[AQ3]
Yes Yes Yes Yes Unclear 4 Insufficient
Yang et al. [39] Yes Yes Yes Yes No 4 Insufficient
Levels of moderation evidence: Confirmatory Evidence: All 5 items met; Exploratory Evidence: Final 3 items met;
Insufficient Evidence: Failure to meet final 3 items.
Discussion
This review aimed to identify moderators or potential moderators of the effects of three commonly used first-line
treatments: advice and pain relief, strengthening and/or mobilising exercise delivered by a physiotherapist, and corti‐
costeroid injection in patients with musculoskeletal shoulder pains. Six relevant trials studied potential treatment
moderators, and 16 trials included suggestions regarding potential moderators (Figure 3). Only one study conducted a
robust moderation analysis: presence of painful arc (versus no painful arc) led to a smaller effect on shoulder disabili‐
ty of graded exercise therapy compared with usual care only, although the test for interaction was not (or perhaps
borderline) statistically significant (p = 0.05) with the confidence interval including a null result (−28.1 to 0.1). Nine
other potential moderators of outcome were identified, however, these were supported by insufficient level evidence
(Figure 3), and these do not constitute high quality evidence of moderation of treatment effect.
Figure 3. Summary of review findings.
Methodological issues identified
Methodological pitfalls in identifying treatment effect moderators are highlighted in this review, including impor‐
tance of a priori, evidence-based hypotheses, adequate statistical power, and interaction testing between potential
moderators and treatments. This review found more exploratory subgroup analyses than pre-planned moderation
analyses, with only one trial having conducted moderation analysis in a robust manner according to published quality
criteria [35]. Post-hoc moderation or sub group analyses are especially prone to error due to testing several hypothe‐
ses (multiplicity) and having insufficient sample sizes to test these hypotheses robustly [42]. Since moderation analy‐
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sis requires at least four times the sample size of a routine RCT to test the interaction between prognostic factor and
treatment [43], interactions between potential moderators and outcome in trials without a priori hypotheses of moder‐
ation and sufficiently large sample size are likely to be statistically insignificant due to original trials being under‐
powered to detect clinically important moderators of treatment effect [25,44]. Therefore, and also to avoid spurious
findings (type 1 error) and the associated risks of testing every possible hypothesis, Pincus et al. [24] recommend less
than 5 a priori, evidence/theory-based subgroup hypotheses.
Turner et al. [45] recommend adjustment of p values to a more conservative p < 0.01 when testing more than three
hypotheses. All studies identified by this review failed to conduct this adjustment, increasing risk of type 1 error.
Whilst adjustment of p values should indeed be considered in future moderation analyses, this field would benefit
more from the conduct of large, sufficiently powered trials. Such trials could compare commonly used interventions
for shoulder pain and investigate a limited number of plausible patient or shoulder pain characteristics as potential
moderators of effect. As the PROGnosis RESearch Strategy (PROGRESS) Partnership [46] highlight, robust statisti‐
cal methodology has the potential to offer clinically informative moderation and sub-group analysis that would help
build understanding of which patients might benefit most from these specific treatments.
Comparison with other reviews and studies
Previous reviews have not investigated moderators of treatment effect in shoulder pain. Chester et al. [17] identi‐
fied predictors of response to physiotherapy treatment in patients with shoulder pain, however, prediction of outcome
of physiotherapy is not simply equivalent to the identification of moderators for physiotherapy treatment outcome. In
spite of this, some findings were similar to this review: increased baseline disability and longer symptom duration
were predictors of negative outcome of physiotherapy treatment, with inconsistent findings for age and baseline range
of movement. This review’s finding that gender is a potential treatment effect moderator in patients with shoulder
disorders is also in line with Blangsted et al. [47] who demonstrated an interaction between gender and treatment in a
subgroup analysis.
Authors examining other musculoskeletal pain sites have sought to identify moderators of the effect of specific
interventions. In the field of back pain, Underwood et al. [30] identified that treatment preference moderated response
to treatment. In contrast, our review found insufficient evidence to determine whether treatment preference is a poten‐
tial moderator for patients with shoulder pain. Gurung et al. [48] reviewed moderators for low back pain treatments
and identified a moderate level of evidence for age, employment status, narcotic medication use, treatment expecta‐
tion and education as treatment moderators. In contrast, we did not find any confirmatory evidence for age or treat‐
ment expectation as treatment moderators for patients with shoulder pain. Gurung et al. also identified a weaker level
of evidence for gender, psychological distress, pain/disability and quality of life as treatment moderators for low back
pain. Our review concurs, as we found some exploratory level evidence for age, pain/disability and quality of life as
treatment moderators for patients with shoulder pain.
Chester et al. [49] demonstrated in a single-treatment cohort study that psychological factors were consistently as‐
sociated with patient-rated outcome. However, as previously stated, prediction of outcome of a single treatment does
not equate to evidence of treatment effect modification. Similarly, Coronado et al. [50] highlight that optimism de‐
creases the negative relationship between pain catastrophising and function in patients receiving either exercise-based
treatment or manual therapy. This suggests that there may be scope in future to explore further the relevance of psy‐
chologically informed physiotherapy in patients with shoulder pain. However, this analysis consisted of pooling of
data from two separate arms in their RCT (exercises versus manual therapy). Although Coronado et al. [50] refer to
optimism as a moderator of the relationship between catastrophising and function, due to having pooled both treat‐
ment groups into one group, it was not possible to test an interaction between treatment and optimism. Therefore, this
does not represent a moderation of treatment effect, in the manner that this review concerns.
In people with musculoskeletal pain more broadly, Turner et al. [45] failed to demonstrate that greater baseline
somatisation, greater depressive symptoms, higher number of pain sites, more rumination, catastrophising, and higher
perceived stress moderated effect of cognitive behavioural therapy. The study by Turner et al. highlights the challeng‐
es in demonstrating moderation of treatment effect, even with good methods and sound hypotheses. Therefore, it is
not currently known whether other psychological factors (anxiety, depression, psychosocial determinants of health
and well-being including work-load and sport participation, chronic widespread pain, multi-site pain, employment
status, analgesic medication and education) that have been identified as predictors of outcome in shoulder pain
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[20,51,52] also moderate treatment effect of the three commonly used shoulder pain interventions explored in this
review.
Strengths and limitations
The strengths of this review included the use of search strategies from existing relevant systematic reviews [27,28]
to ensure our searches were appropriately specified and the risk of missing relevant publications was minimised. Our
classification of the results into two levels of evidence: (i) studies aiming to identify or test moderators and (ii) stud‐
ies suggesting potential moderators, allows for a clearer interpretation of the current evidence in the literature. Meth‐
odological appraisal of moderation analyses using a published tool also facilitated a conservative interpretation of the
strength of evidence about potential moderators.
A limitation of our review was that it was not possible to perform a meta-analysis due to the heterogeneity of ex‐
isting studies, but testing of moderators will generally require a meta-analysis of individual patient data from multiple
trials, as candidate moderators generally concerns patient-level factors [53]. However, our review was still able to
identify some potential moderators and one confirmed moderator of commonly used shoulder pain treatments.
Conclusion
This review has found little evidence for moderators and, based in an assessment using the Pincus criteria, high‐
lighted many methodological issues in the conduct of moderation analysis in trials of primary care interventions for
shoulder pain. The CHAMP checklist [54] has recently been introduced and is specifically designed for the critical
appraisal of moderation analysis. Future researchers can use this checklist during design, execution and reporting
stages of future moderation analyses. At present, the quantity and quality of existing evidence exploring moderators
of treatment effect in shoulder pain is insufficient and does not inform clinical decision-making. Aside from the sin‐
gle treatment moderator identified by this review (Table 4), other suggested potential moderators identified (Table 6)
are heavily caveated, as they have not yet been statistically tested. Future moderation analysis to explore whether the
different factors identified by this review do indeed moderate response to specific treatments would be useful, provid‐
ing that existing methodological recommendations about how to identify treatment moderators (considered in this re‐
view) are followed.





































Short Wave), three times
weekly, duration unclearCon‐
tinuous supra-scapular nerve
block (SSNB) under ultra‐
sound guidance in addition to
rehabilitation programme,
three times weekly, duration
unclear Intra-articular cortico‐
steroid injection in addition to
rehabilitation programme
In those who received
SSNB, having a diagnosis of
rheumatoid arthritis (B) was
associated with improvement
in pain (mean ± SD SPADI
pain for SSNB: 44±9; injec‐
tion: 55±8.7; rehabilitation:
62.5±8, p = 0.018) and disa‐




having frozen shoulder (B)
was associated with im‐
provement in disability (total

















Physiotherapy and a non-ster‐
oidal anti-inflammatory drug
Analysis stratified by base‐
line symptom duration (B)
but no differences between
interventions were found.
















10 active treatments com‐
prised a manual therapy and
home exercise programme, 10
weeks10 Placebo treatment
comprised inactive ultrasound
therapy and application of an
inert gel, 10 weeks
Whether pain, dysfunction,
or both are the patients’ pri‐
mary problems (C) may help
indicate what kind of treat‐
























point release, intermittent ice
application, stretching exerci‐
ses), weekly up to 12 weeks
Wait-and-See
Number of muscles with ac‐
tive trigger points (B), Pas‐
sive ROM (B), Baseline Dis‐
ability (DASH) (B). Multiple
linear regression with base‐
line DASH score as a covari‐
ate demonstrated a signifi‐
cantly higher DASH ques‐
tionnaire score at 12 weeks
of 7.447 (95% CI: 2.14,
12.75) in the intervention
group compared with the
control group. Adjustment
for covariates (number of
muscles with active trigger
points and passive ROM)
had no influence on this re‐




























All patients were taught a
simple, 10-minute exercise
programme and randomised
into 1 of 4 groups:Corticoste‐
roid injection followed by su‐
pervised physiotherapy) Cor‐
ticosteroid injection alone
Saline injection followed by
supervised physiotherapy Sal‐
ine injection alone
Pain at rest, pain frequency,
pain on movement, night
pain and joint end-feel (C)
implied as different treat‐














SPADI 12/52 Injection plus exercise Exer‐
cise only, up to 12 weeks
Baseline pain and disability
score (B), baseline pain VAS
(B) entered as covariates.









Constant Score 6/12 Physiotherapy (individualised
treatment), < 6 monthsControl
(No treatment)


























sessions weekly, up to 12
weeksSupportive therapy and
exercises within the pain lim‐
its (supervised neglect group)




















weekly, up to 12 weeksRadial
extracorporeal shockwave
treatment (REST), weekly for
4–6 weeks
Gender (adjusted for in re‐
gression and analysis strati‐
fied for gender) (B). At 18
weeks the treatment effect
was −8.4 SPADI points
(95% CI: −16.5, −0.6, p = 
0.047) in favour of super‐
vised exercise. The treatment
effect was consistent when













Two injections at 21-day in‐
tervalsNo treatment (control
group)
Failure of conservative treat‐
ments, increasing night pain,
acute or inflammatory stages






























up to 8 20 min sessions in 6
weeks
Age, sex, symptom duration,
shoulder restriction, painful
arc of movement, restricted






















4/52 Standard exercise groupStan‐
dard exercise plus Wii group
Responders to Wii interven‐
tion more likely than non-
responders to report having
baseline shoulder symptoms
(X2= 6.05; p = 0.014) &
hand symptoms (X2= 6.35; p













SPADI, ROM, 3/52 IbuprofenIbuprofen and phys‐






























with 4 cc of 1% lidocaine,
plus naproxen Subacromial
bursa injection with 3 cc of
1%lidocaine and 1cc of 40 
mg/ml triamcinolone, plus
naproxen Subacromial bursa
injection with 3 cc of 1% lido‐
caine and 1 cc of 40 mg/ml
triamcinolone, plus placebo
pill Subacromial bursa injec‐
tion with 4 cc of 1% lido‐
caine, plus placebo pill
Symptom duration (C), pre-













































4/52 Massage on the posterior del‐
toid, infraspinatus, and teres
minor, 18 min, twice weekly
for 4 weeksControl Treat‐
ment: Light hand touch on the
muscles, 10 min, twice week‐
ly for 4 weeks
Less baseline symptom dura‐
tion, muscle tightness &
shoulder function (all B) in
responders to massage com‐
pared with non-responders,
p < 0.005). Symptom dura‐




eral Internal Rotation in de‐
grees (°): R: 68.6 ± 12.1, NR:
32.2 ± 10.8. FLEX-SF: R:
43.3 ± 4.8, NR: 38.2 ± 2.8
A: exploratory subgroup analysis; B: prognostic factors or potential confounders but not tested as moderator; C: at‐
tributes narratively mentioned or discussed as potential moderators but not tested in any way as a moderator. Statisti‐
cal data presented where shown in publication by trial authors.
By establishing a list of 30 patient attributes thought to moderate or potentially moderate treatment effect, this re‐
view has begun the process of exploring the evidence of moderators of treatment effect and their role in first-line
clinical decision-making for shoulder pain. However, due to lack of evidence, many commonly considered patient
attributes do not feature in this review, including psychological attributes such as anxiety or depression, other deter‐
minants of health and wellbeing including workload and sport participation and chronic widespread pain or multi-site
pain. It is not currently known whether they moderate treatment effect of the three commonly used primary care inter‐
ventions for musculoskeletal shoulder pain and have a role in helping clinicians choose specific treatments for indi‐
vidual patients. Expert clinician consensus has previously been shown to reflect most statistically selected predictors
of outcome and also suggests additional predictors not identified by statistical selection [20]. Therefore, future re‐
search should seek to identify expert clinician consensus on the likely most appropriate patient attributes to include in
an a priori, appropriately powered and statistically robust moderation analysis in shoulder pain.
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